Kashmir Life11d
Kashmiri Scientist’s Jamia Millia Team Develops AI Technology for Life-Saving Oral Cancer Detection
Kashmiri scientist and Jamia Millia Islamia team secure a patent for pioneering AI-driven technology, transforming oral ...
Pharmaceutical Technology12d
Nivolumab by Bristol-Myers Squibb for Paranasal Sinus And Nasal Cavity Cancer: Likelihood of Approval
Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.
Pharmaceutical Technology12d
Nivolumab by Bristol-Myers Squibb for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Triple-Negative Breast Cancer (TNBC).